Full Text
The Evaluation Of Assumptions In Cost-Effectiveness Model Development – A Case Of Dabigatran

Abstract

Authors

A Janzic I Locatelli

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×